Suppr超能文献

pHLIP介导的膜不透性分子向细胞内的转运。

pHLIP-mediated translocation of membrane-impermeable molecules into cells.

作者信息

Thévenin Damien, An Ming, Engelman Donald M

机构信息

Department of Molecular Biophysics and Biochemistry, Yale University, P.O. Box 208114, New Haven, CT 06520-8114, USA.

出版信息

Chem Biol. 2009 Jul 31;16(7):754-62. doi: 10.1016/j.chembiol.2009.06.006.

Abstract

Our goal is to define the properties of cell-impermeable cargo molecules that can be delivered into cells by pH (Low) Insertion Peptide (pHLIP), which can selectively target tumors in vivo based on their acidity. Using biophysical methods and fluorescence microscopy, we show that pHLIP can successfully deliver polar and membrane-impermeable cyclic peptides linked to its C terminus through the membranes of lipid vesicles and cancer cells. Our results also indicate that the translocation of these cargo molecules is pH dependent and mediated by transmembrane helix formation. Since a broad range of cell-impermeable molecules is excluded from discovery efforts because they cannot traverse membranes on their own, we believe that pHLIP has the potential to expand therapeutic options for acidic tissues such as tumors and sites of inflammation.

摘要

我们的目标是确定细胞不可渗透的货物分子的特性,这些分子可通过pH(低)插入肽(pHLIP)递送至细胞中,pHLIP能够基于肿瘤的酸度在体内选择性地靶向肿瘤。通过生物物理方法和荧光显微镜,我们表明pHLIP能够成功地将与其C末端相连的极性且膜不可渗透的环肽通过脂质囊泡和癌细胞的膜递送进去。我们的结果还表明,这些货物分子的转运是pH依赖性的,并且由跨膜螺旋的形成介导。由于广泛的细胞不可渗透分子因其自身无法穿过膜而被排除在发现工作之外,我们认为pHLIP有潜力扩大针对诸如肿瘤和炎症部位等酸性组织的治疗选择。

相似文献

1
pHLIP-mediated translocation of membrane-impermeable molecules into cells.
Chem Biol. 2009 Jul 31;16(7):754-62. doi: 10.1016/j.chembiol.2009.06.006.
2
Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
Arch Biochem Biophys. 2015 Jan 1;565:40-8. doi: 10.1016/j.abb.2014.11.002. Epub 2014 Nov 18.
3
Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
Mol Pharm. 2020 Feb 3;17(2):461-471. doi: 10.1021/acs.molpharmaceut.9b00883. Epub 2020 Jan 13.
4
Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2811-E2818. doi: 10.1073/pnas.1715350115. Epub 2018 Mar 5.
5
pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.
Mol Membr Biol. 2010 Oct;27(7):341-52. doi: 10.3109/09687688.2010.509285. Epub 2010 Oct 13.
7
Antiproliferative effect of pHLIP-amanitin.
Biochemistry. 2013 Feb 19;52(7):1171-8. doi: 10.1021/bi301647y. Epub 2013 Feb 8.
8
Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide.
Biochemistry. 2011 Nov 29;50(47):10215-22. doi: 10.1021/bi2009773. Epub 2011 Nov 4.
9
pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation.
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20246-50. doi: 10.1073/pnas.1014403107. Epub 2010 Nov 3.

引用本文的文献

1
Enhancing Anti-Cancer Immune Response by Acidosis-Sensitive Nanobody Display.
J Membr Biol. 2024 Dec;257(5-6):391-401. doi: 10.1007/s00232-024-00322-3. Epub 2024 Sep 10.
2
Targeted acidosis mediated delivery of antigenic MHC-binding peptides.
Front Immunol. 2024 Apr 11;15:1337973. doi: 10.3389/fimmu.2024.1337973. eCollection 2024.
3
Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.
Front Pharmacol. 2024 Mar 13;15:1355893. doi: 10.3389/fphar.2024.1355893. eCollection 2024.
4
MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma.
BMC Cancer. 2023 Sep 8;23(1):843. doi: 10.1186/s12885-023-11352-w.
5
Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.
Pharmaceutics. 2022 Oct 31;14(11):2346. doi: 10.3390/pharmaceutics14112346.
6
PET Imaging of Acidic Tumor Environment With Zr-labeled pHLIP Probes.
Front Oncol. 2022 May 19;12:882541. doi: 10.3389/fonc.2022.882541. eCollection 2022.
7
Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy.
Bioact Mater. 2022 Feb 11;18:42-55. doi: 10.1016/j.bioactmat.2022.02.001. eCollection 2022 Dec.
8
Applications and evolution of melittin, the quintessential membrane active peptide.
Biochem Pharmacol. 2021 Nov;193:114769. doi: 10.1016/j.bcp.2021.114769. Epub 2021 Sep 17.
9
Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications.
Front Bioeng Biotechnol. 2021 Jul 1;9:701504. doi: 10.3389/fbioe.2021.701504. eCollection 2021.
10
Non-coding RNAs and potential therapeutic targeting in cancer.
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188491. doi: 10.1016/j.bbcan.2020.188491. Epub 2020 Dec 13.

本文引用的文献

1
Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane.
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15340-5. doi: 10.1073/pnas.0804746105. Epub 2008 Sep 30.
2
Dissecting the membrane binding and insertion kinetics of a pHLIP peptide.
Biochemistry. 2008 Aug 12;47(32):8250-2. doi: 10.1021/bi801103x. Epub 2008 Jul 18.
3
Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors.
Biophys J. 2008 Jul;95(1):225-35. doi: 10.1529/biophysj.107.124156. Epub 2008 Mar 21.
4
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):548-58. doi: 10.1016/j.addr.2007.10.008. Epub 2007 Nov 28.
5
Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
AAPS J. 2007 May 11;9(2):E128-47. doi: 10.1208/aapsj0902015.
6
A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.
Biophys J. 2007 Oct 1;93(7):2363-72. doi: 10.1529/biophysj.107.109967. Epub 2007 Jun 8.
7
Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.
Proc Natl Acad Sci U S A. 2007 May 8;104(19):7893-8. doi: 10.1073/pnas.0702439104. Epub 2007 May 1.
8
Regulation of tumor pH and the role of carbonic anhydrase 9.
Cancer Metastasis Rev. 2007 Jun;26(2):299-310. doi: 10.1007/s10555-007-9064-0.
9
Peptide-guided gene delivery.
AAPS J. 2007 Feb 9;9(1):E18-29. doi: 10.1208/aapsj0901003.
10
Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Life Sci. 2007 Jan 23;80(7):659-64. doi: 10.1016/j.lfs.2006.10.011. Epub 2006 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验